Related Experiment Video
Updated: May 22, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders
Anthony W S Chan1, Jannet Kocerha
1Yerkes National Primate Research Center Atlanta, GA, USA.
Abstract:
The microRNA (miRNA) class of non-coding RNAs exhibit a diverse range of regulatory roles in neuronal functions that are conserved from lower vertebrates to primates. Disruption of miRNA expression has compellingly been linked to pathogenesis in neuropsychiatric and neurodegenerative disorders, such as schizophrenia, Alzheimer's disease, and autism. The list of transcript targets governed by a single miRNA provide a molecular paradigm applicable for therapeutic intervention. Indeed, reports have shown that specific manipulation of a miRNA in cell or animal models can significantly alter phenotypes linked with neurological disease. Here, we review how a diverse range of biological systems, including Drosophila, rodents, and primates such as monkeys and humans, can be integrated into the translation of miRNAs as novel clinical targets.
Insights
MicroRNAs (miRNAs) regulate neuronal functions and their dysregulation is linked to neurological diseases. Manipulating miRNAs in various models shows therapeutic potential for conditions like Alzheimer's and autism.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are non-coding RNAs with crucial regulatory roles in neuronal functions across species.
- Aberrant miRNA expression is implicated in the pathogenesis of neuropsychiatric and neurodegenerative disorders, including schizophrenia, Alzheimer's disease, and autism.
Purpose of the Study:
- To review the regulatory roles of miRNAs in neuronal functions.
- To explore the potential of miRNAs as therapeutic targets for neurological diseases.
Main Methods:
- Review of existing literature on miRNA function and neurological disorders.
- Analysis of studies involving miRNA manipulation in various model systems (Drosophila, rodents, primates).
Main Results:
- miRNAs are conserved regulators of neuronal functions.
- Specific miRNA dysregulation is associated with major neurological diseases.
- Experimental manipulation of miRNAs can modify disease-related phenotypes in model organisms.
Conclusions:
- miRNAs represent a promising class of therapeutic targets for neurological diseases.
- Diverse biological systems, from invertebrates to primates, can be utilized to translate miRNA research into clinical applications.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
MicroRNAs
MicroRNAs
MicroRNAs
Alzheimer Disease ll: Pathophysiology
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

